Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Degboé, Yannick ^a,b   Fruchon, Séverine ^b   Baron, Michel ^b   Nigon, Delphine ^a,b   Turrin, Cédric O ^c   Caminade, Anne Marie ^c   Poupot, Rémy ^b   Cantagrel, Alain ^a,b   Davignon, Jean Luc ^a,b  

^a CHU PURPAN   (France)

^b University of Toulouse III   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZA BIS PHOSPHONATE; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRIMER; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHONIC ACID DERIVATIVE; T6 ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; BISPHOSPHONIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE DERIVED DENDRITIC CELL; PHENOTYPE; PROTEIN EXPRESSION; BIOSYNTHESIS; DRUG EFFECTS; IMMUNOLOGY; MONOCYTE; BLOOD DONOR; CELL ACTIVATION; DRUG MECHANISM; PROTEIN FUNCTION;

CELL DIFFERENTIATION; CYTOKINES; DENDRIMERS; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MONOCYTES; ORGANOPHOSPHONATES;

EID: 84902085401     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4546     Document Type: Article

References (41)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
2. Lundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 2007, 9:202. 10.1186/ar2107, 1860060, 17306038.
3. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233:233-255. 10.1111/j.0105-2896.2009.00859.x, 2913689, 20193003.
4. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304. 10.1038/nri2062, 17380158.
5. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686. 10.1016/j.it.2004.09.015, 15530839.
6. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006, 80:1298-1307. 10.1189/jlb.0406249, 2642590, 16905575.
7. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998, 392:245-252. 10.1038/32588, 9521319.
8. Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011, 241:206-227. 10.1111/j.1600-065X.2011.01015.x, 3094730, 21488899.
9. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995. 10.1038/ni1112, 15454922.
10. Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM, Tak PP, Haines GK, Nicchitta CV, Pope RM. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 2009, 182:4965-4973. 10.4049/jimmunol.0801563, 2814438, 19342676.
11. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000, 164:558-561. 10.4049/jimmunol.164.2.558, 10623794.
12. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, Schreurs BW, van den Berg WB, Radstake TR. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006, 176:7021-7027. 10.4049/jimmunol.176.11.7021, 16709864.
13. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Götte M, Malle E, Schaefer RM, Gröne HJ. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005, 115:2223-2233. 10.1172/JCI23755, 1174916, 16025156.
14. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001, 167:2887-2894. 10.4049/jimmunol.167.5.2887, 11509636.
15. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111. 10.1084/jem.20001858, 2196009, 11781369.
16. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004, 76:514-519. 10.1189/jlb.0304127, 15178705.
17. Musiani M, Zerbini M, Ferri S, Plazzi M, Gentilomi G, La Placa M. Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1987, 46:837-842. 10.1136/ard.46.11.837, 1003402, 2827590.
18. Gaudreault E, Fiola S, Olivier M, Gosselin J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 2007, 81:8016-8024. 10.1128/JVI.00403-07, 1951286, 17522215.
19. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 2009, 83:1492-1500. 10.1128/JVI.00671-08, 2620898, 19019963.
20. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596. 10.1128/JVI.77.8.4588-4596.2003, 152130, 12663765.
21. Lotz M, Roudier J. Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects. Rheumatol Int 1989, 9:147-152.
22. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008, 22:883-896. 10.1016/j.berh.2008.09.007, 19028369.
23. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680. 10.1038/90609, 11477402.
24. Poupot M, Griffe L, Marchand P, Maraval A, Rolland O, Martinet L, L'Faqihi-Olive FE, Turrin CO, Caminade AM, Fournie JJ, Majoral JP, Poupot R. Design of phosphorylated dendritic architectures to promote human monocyte activation. FASEB J 2006, 20:2339-2351. 10.1096/fj.06-5742com, 17077311.
25. Hayder M, Poupot M, Baron M, Nigon D, Turrin CO, Caminade AM, Majoral JP, Eisenberg RA, Fournie JJ, Cantagrel A, Poupot R, Davignon JL. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med 2011, 3:81ra35.
26. Fruchon S, Poupot M, Martinet L, Turrin CO, Majoral JP, Fournie JJ, Caminade AM, Poupot R. Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer. J Leukoc Biol 2009, 85:553-562.
27. Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 2008, 226:41-56. 10.1111/j.1600-065X.2008.00707.x, 2630590, 19161415.
28. Wittmann M, Zwirner J, Larsson VA, Kirchhoff K, Begemann G, Kapp A, Gotze O, Werfel T. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol 1999, 162:6763-6769.
29. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118. 10.1084/jem.179.4.1109, 2191432, 8145033.
30. Hayes MP, Wang J, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 1995, 86:646-650.
31. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998, 10:1593-1598. 10.1093/intimm/10.11.1593, 9846688.
32. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006, 27:17-23. 10.1016/j.it.2005.10.003, 16290228.
33. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765. 10.1146/annurev.immunol.19.1.683, 11244051.
34. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000, 106:1481-1488. 10.1172/JCI11176, 387259, 11120755.
35. Wei S, Teitelbaum SL, Wang MW, Ross FP. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. Endocrinology 2001, 142:1290-1295.
36. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001, 182:68-79. 10.1034/j.1600-065X.2001.1820105.x, 11722624.
37. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181. 10.1038/nri2711, 20154735.
38. Lutzky V, Hannawi S, Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther 2007, 9:219. 10.1186/ar2200, 2206384, 17850683.
39. Fruchon S, Caminade AM, Abadie C, Davignon JL, Combette JM, Turrin CO, Poupot R. An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis. Molecules 2013, 18:9305-9316. 10.3390/molecules18089305, 23921793.
40. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 1997, 158:5501-5506.
41. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132. 10.1038/ni1254, 16200070.